Trials / Not Yet Recruiting
Not Yet RecruitingNCT06143722
Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases.
Camrelizumab Plus Chemotherapy in Combination With Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases: a Randomized Controlled Phase II Clinical Study
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 63 (estimated)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, prospective phase II trial was conducted to explore the timing of radiotherapy intervention in combination with chemotherapy and immunotherap in order to provide an effective treatment for patients with advanced esophageal squamous carcinoma with oligometastases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | simultaneous with radiotherapy | Chemotherapy combined with immunotherapy simultaneous with radiotherapy |
| RADIATION | synchronous with radiotherapy | Chemotherapy combined with immunotherapy synchronous with radiotherapy |
Timeline
- Start date
- 2023-11-30
- Primary completion
- 2025-11-30
- Completion
- 2026-11-30
- First posted
- 2023-11-22
- Last updated
- 2023-11-22
Source: ClinicalTrials.gov record NCT06143722. Inclusion in this directory is not an endorsement.